Worth Financial Advisory Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,369
Closed -$1.47M 125
2025
Q4
$1.47M Buy
1,369
+27
+2% +$25.8K 0.71% 31
2025
Q3
$1.02M Buy
1,342
+54
+4% +$40.2K 0.57% 37
2025
Q2
$1M Buy
1,288
+67
+5% +$52.1K 0.62% 37
2025
Q1
$1.01M Buy
1,221
+918
+303% +$764K 0.64% 37
2024
Q4
$234K Sell
303
-407
-57% -$337K 0.14% 140
2024
Q3
$629K Buy
+710
New +$638K 0.37% 67

Other funds holding LLY

Worth Financial Advisory Group's LLY Position: Q1 2026 in Review

Worth Financial Advisory Group sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 1,369 shares — an estimated $1.47M sold.

Worth Financial Advisory Group first reported a position in LLY in Q3 2024 and held it in 6 quarters. The position peaked at $1.47M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Worth Financial Advisory Group reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Worth Financial Advisory Group sold 1,369 Eli Lilly shares in Q1 2026, an estimated $1.47M.
  • Worth Financial Advisory Group first reported a position in Eli Lilly in Q3 2024 and held it in 6 quarters.
  • Worth Financial Advisory Group's Eli Lilly position peaked at $1.47M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Worth Financial Advisory Group's 13F filing for Q1 2026, filed 4 May 2026.